ClinicalTrials.gg
RecruitingNCT06138249VITDUpdated Nov 25, 2025

Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels

An interventional study of Vitamin D in Hypovitaminosis D, sponsored by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-11-25.

Sponsored by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Jul 2023; still recruiting 3 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 154 studies testing Vitamin D in Vitamin D Deficiency — 15 open to participants now, 16 under way, none of them phase 3. Vitamin D · Vitamin D Deficiency.

Planned enrollment
66th of 153
90 · median 75
Started
2023
with 8 others
No phase
87 of 154
12 open now
Primary completion
2025-12
later than 10 of 15 live
Registered
141st of 154
by date

Among the 154 studies testing Vitamin D in Vitamin D Deficiency, this one is the 66th largest by planned enrollment of the 153 interventional ones that give a count, is one of 9 that started in 2023, is one of 87 with no phase, reaches primary completion later than 10 of the 15 other live ones, and was the 141st registered.

Vitamin D Deficiency

800 studies on the registry are indexed under Vitamin D Deficiency; 60 are open to participants now.

Browse Vitamin D Deficiency studies →

Open to participants now

15 of the 154 studies testing Vitamin D in Vitamin D Deficiency are open now, in 8 countries. Recruiting first, the newest first:

9 more — sign in →

By country, each count listing its studies:

All 15 open studies →

About Vitamin D

No approval found in the FDA or EMA files read. How studies give it is on its page →

Who these studies take

Of the 37 Vitamin D Deficiency studies recruiting now, 16 (43%) set no upper age limit and 18 (49%) stop at 75 or younger; 10 take children under 18; 11 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 154 studies testing Vitamin D in Vitamin D Deficiency, or all of them as a file.
02

Study summary

Patients with hypovitaminosis D are randomized into three arms of treatment:

Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment

Read the detailed description

Patients with hypovitaminosis D are randomized into three arms of treatment:

Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment to support the best dosage of Vitamin D intake.

03

Conditions studied

  • Hypovitaminosis D

Browse trials for

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Hypovitaminosis D (\<20ng/mL)

Exclusion criteria

Exclusion Criteria:

  • Osteoporosis (T score \<-2.5SD)
  • Renal or hepatic diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Calcifediol each month

    Calcifediol 0,266 mg each month

    Dietary Supplement: Vitamin D

  • Experimental
    Cholecalciferol 25.000 UI

    Cholecalciferol 25000UI each 15 days

    Dietary Supplement: Vitamin D

  • Experimental
    Calcifediol 4 drops each day

    Calcifediol 4 drops each day

    Dietary Supplement: Vitamin D

Interventions

06

What researchers measure

Primary outcomes

  1. level of Vitamin D

    Blood dosage of Vitamin D

    Time frame: Between recruitment and 1 month

  2. level of Vitamin D

    Blood dosage of vitamin D

    Time frame: Between recruitment and 6 month

Secondary outcomes

  1. DEXA

    DEXA is a radiographic measurement of Bone Mass

    Time frame: Between recruitment and 18 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Paterson C. Vitamin D deficiency: a diagnosis often missed. Br J Hosp Med (Lond). 2011 Aug;72(8):456-8, 460-2. doi: 10.12968/hmed.2011.72.8.456. PubMed 21841591 ↗
  • Castano L, Madariaga L, Grau G, Garcia-Castano A. 25(OH)Vitamin D Deficiency and Calcifediol Treatment in Pediatrics. Nutrients. 2022 Apr 29;14(9):1854. doi: 10.3390/nu14091854. PubMed 35565821 ↗
  • Haddow JE. Vitamin D and rickets: much has been accomplished, but there is room for improvement. J Med Screen. 2011;18(2):58-9. doi: 10.1258/jms.2011.011059. No abstract available. PubMed 21852696 ↗

Related links

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2023 (actual). Primary completion is estimated for Dec 2025, 29 months after the start.

Of 167 non-industry interventional studies with no phase under Vitamin D Deficiency, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 29. This study's planned 29 months is above that.

Counting every sponsor, half of 169 studies reached it within 11 months; a quarter within 4 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2023
First posted
Nov 18, 2023
StartActual
Jul 1, 2023
Primary completionEst.
Dec 30, 2025
CompletionEst.
Dec 30, 2025
Last update
Nov 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06138249
Lead sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Collaborators
Silvana De Giorgi, Davide Bizzoca, Angela Notarnicola
Responsible party
Sponsor
First posted
Nov 18, 2023
Start date
Jul 1, 2023
Primary completion
Dec 30, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Nov 25, 2025

Study contacts

Silvana De Giorgi, AP
Contact
silvana.degiorgi@uniba.it
3389821930
Angela Notarnicola, AP
study chair · University of Bari

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Vitamin D

Start the discussion